Zeltiq Aesthetics Inc 4/A
4/A · Zeltiq Aesthetics Inc · Filed Jun 20, 2013
Insider Transaction Report
Form 4/AAmended
Tatsutani Kristine N
CTO and VP
Transactions
- Sale
Common Stock
2013-06-17$5.80/sh−4,413$25,595→ 30,769 total - Exercise/Conversion
Common Stock
2013-06-14$2.83/sh+14,127$39,923→ 44,896 total - Sale
Common Stock
2013-06-14$5.80/sh−14,127$81,937→ 30,769 total - Exercise/Conversion
Common Stock
2013-06-17$2.83/sh+4,413$12,471→ 35,182 total - Exercise/Conversion
Stock Option (Right to buy)
2013-06-14−14,127→ 94,429 totalExercise: $2.83Exp: 2021-05-17→ Common Stock (5,696 underlying) - Exercise/Conversion
Stock Option (Right to buy)
2012-06-17−4,413→ 82,310 totalExercise: $2.83Exp: 2021-05-17→ Common Stock (12,119 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 13, 2012.
- [F2]25% of the granted 117,696 shares became exercisable on 5/18/2012. The remaining vests in a series of 36 equal monthly installments; provided the Reporting Person continues to provide service to ZELTIQ Aesthetics, Inc.